Literature DB >> 17438062

First case of emergence of atovaquone resistance in Plasmodium falciparum during second-line atovaquone-proguanil treatment in South America.

Eric Legrand, Magalie Demar, Béatrice Volney, Marie-Thérèse Ekala, Marc Quinternet, Christiane Bouchier, Thierry Fandeur, Christophe Rogier, Bernard Carme, Odile Mercereau Puijalon, Philippe Esterre.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17438062      PMCID： PMC1891413          DOI： 10.1128/AAC.01532-06

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  12 in total

1.  Emergence of atovaquone-proguanil resistance during treatment of Plasmodium falciparum malaria acquired by a non-immune north American traveller to west Africa.

Authors:  Susan Kuhn; M John Gill; Kevin C Kain
Journal:  Am J Trop Med Hyg       Date:  2005-04       Impact factor: 2.345

2.  Mutations in Plasmodium falciparum cytochrome b that are associated with atovaquone resistance are located at a putative drug-binding site.

Authors:  M Korsinczky; N Chen; B Kotecka; A Saul; K Rieckmann; Q Cheng
Journal:  Antimicrob Agents Chemother       Date:  2000-08       Impact factor: 5.191

3.  Genetic diversity and structure of African Plasmodium falciparum populations in urban and rural areas.

Authors:  Hervé Bogreau; François Renaud; Housem Bouchiba; Patrick Durand; Serge-Brice Assi; Marie-Claire Henry; Eric Garnotel; Bruno Pradines; Thierry Fusai; Boubacar Wade; Eric Adehossi; Philippe Parola; Mohamed Ali Kamil; Odile Puijalon; Christophe Rogier
Journal:  Am J Trop Med Hyg       Date:  2006-06       Impact factor: 2.345

4.  Atovaquone, a broad spectrum antiparasitic drug, collapses mitochondrial membrane potential in a malarial parasite.

Authors:  I K Srivastava; H Rottenberg; A B Vaidya
Journal:  J Biol Chem       Date:  1997-02-14       Impact factor: 5.157

5.  Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance.

Authors:  S J Foote; D Galatis; A F Cowman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

6.  Malarone treatment failure and in vitro confirmation of resistance of Plasmodium falciparum isolate from Lagos, Nigeria.

Authors:  Quinton L Fivelman; Geoffrey A Butcher; Ipemida S Adagu; David C Warhurst; Geoffrey Pasvol
Journal:  Malar J       Date:  2002-02-08       Impact factor: 2.979

7.  Efficacy and pharmacokinetics of atovaquone and proguanil in children with multidrug-resistant Plasmodium falciparum malaria.

Authors:  A Sabchareon; P Attanath; P Phanuaksook; P Chanthavanich; Y Poonpanich; D Mookmanee; T Chongsuphajaisiddhi; B M Sadler; Z Hussein; C J Canfield; D B Hutchinson
Journal:  Trans R Soc Trop Med Hyg       Date:  1998 Mar-Apr       Impact factor: 2.184

8.  Molecular analysis of two local falciparum malaria outbreaks on the French Guiana coast confirms the msp1 B-K1/varD genotype association with severe malaria.

Authors:  Eric Legrand; Beatrice Volney; Anne Lavergne; Caroline Tournegros; Loïc Florent; Doris Accrombessi; Micheline Guillotte; Odile Mercereau-Puijalon; Philippe Esterre
Journal:  Malar J       Date:  2005-06-21       Impact factor: 2.979

9.  Different mutation patterns of atovaquone resistance to Plasmodium falciparum in vitro and in vivo: rapid detection of codon 268 polymorphisms in the cytochrome b as potential in vivo resistance marker.

Authors:  Babett Schwöbel; Michael Alifrangis; Ali Salanti; Tomas Jelinek
Journal:  Malar J       Date:  2003-03-19       Impact factor: 2.979

10.  Malarone treatment failure not associated with previously described mutations in the cytochrome b gene.

Authors:  Ole Wichmann; Marion Muehlen; Holger Gruss; Frank P Mockenhaupt; Norbert Suttorp; Tomas Jelinek
Journal:  Malar J       Date:  2004-06-08       Impact factor: 2.979
View more
  12 in total

1.  First case of emergence of atovaquone-proguanil resistance in Plasmodium falciparum during treatment in a traveler in Comoros.

Authors:  Helene Savini; Hervé Bogreau; Lionel Bertaux; Housem Bouchiba; Philippe Kraemer; Daniel Parzy; Eric Garnotel; Christophe Rogier; Fabrice Simon; Bruno Pradines
Journal:  Antimicrob Agents Chemother       Date:  2008-04-14       Impact factor: 5.191

2.  [Malaria--current diagnosis and therapy].

Authors:  Isabel Barreto Miranda; Thomas Löscher
Journal:  Med Klin (Munich)       Date:  2009-07-15

3.  In vitro monitoring of Plasmodium falciparum drug resistance in French Guiana: a synopsis of continuous assessment from 1994 to 2005.

Authors:  Eric Legrand; Béatrice Volney; Jean-Baptiste Meynard; Odile Mercereau-Puijalon; Philippe Esterre
Journal:  Antimicrob Agents Chemother       Date:  2007-10-22       Impact factor: 5.191

4.  Plasmodium chabaudi chabaudi malaria parasites can develop stable resistance to atovaquone with a mutation in the cytochrome b gene.

Authors:  Ana Afonso; Zoraima Neto; Helena Castro; Dinora Lopes; Ana C Alves; Ana M Tomás; Virgílio D Rosário
Journal:  Malar J       Date:  2010-05-21       Impact factor: 2.979

Review 5.  1,4-naphthoquinones and other NADPH-dependent glutathione reductase-catalyzed redox cyclers as antimalarial agents.

Authors:  Didier Belorgey; Don Antoine Lanfranchi; Elisabeth Davioud-Charvet
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

6.  Within-Host Selection of Drug Resistance in a Mouse Model of Repeated Incomplete Malaria Treatment: Comparison between Atovaquone and Pyrimethamine.

Authors:  Suci Nuralitha; Josephine E Siregar; Din Syafruddin; Jessica Roelands; Jan Verhoef; Andy I M Hoepelman; Sangkot Marzuki
Journal:  Antimicrob Agents Chemother       Date:  2015-10-26       Impact factor: 5.191

7.  Proteomic analysis revealed alterations of the Plasmodium falciparum metabolism following salicylhydroxamic acid exposure.

Authors:  Marylin Torrentino-Madamet; Lionel Almeras; Christelle Travaillé; Véronique Sinou; Matthieu Pophillat; Maya Belghazi; Patrick Fourquet; Yves Jammes; Daniel Parzy
Journal:  Res Rep Trop Med       Date:  2011-09-08

8.  Malaria on the Guiana Shield: a review of the situation in French Guiana.

Authors:  Lise Musset; Stéphane Pelleau; Romain Girod; Vanessa Ardillon; Luisiane Carvalho; Isabelle Dusfour; Margarete S M Gomes; Félix Djossou; Eric Legrand
Journal:  Mem Inst Oswaldo Cruz       Date:  2014-08-13       Impact factor: 2.743

9.  Plasmodium falciparum malaria and atovaquone-proguanil treatment failure.

Authors:  Rémy Durand; Virginie Prendki; Johann Cailhol; Véronique Hubert; Pascal Ralaimazava; Laurent Massias; Olivier Bouchaud; Jacques Le Bras
Journal:  Emerg Infect Dis       Date:  2008-02       Impact factor: 6.883

10.  Sequence analysis of Plasmodium falciparum cytochrome b in multiple geographic sites.

Authors:  Marie-Thérèse Ekala; Nimol Khim; Eric Legrand; Milijaona Randrianarivelojosia; Ronan Jambou; Thierry Fandeur; Didier Menard; Serge-Brice Assi; Marie-Claire Henry; Christophe Rogier; Christiane Bouchier; Odile Mercereau-Puijalon
Journal:  Malar J       Date:  2007-12-17       Impact factor: 2.979
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.